Royal Arc Electrodes IPO Details: Price, Dates & Financials
The Royal Arc Electrodes IPO is a closed SME Bookbuilding offer (Fresh Capital-cum-Offer for Sale) that opened on 14 February 2025. The Royal Arc Electrodes IPO closed on 18 February 2025, with an issue price of ₹120 per share. The Royal Arc Electrodes IPO has a face value of ₹10 and a lot size of 1,200 shares. The Royal Arc Electrodes IPO is listed on 24 February 2025. The Royal Arc Electrodes IPO allotment was scheduled for 19 February 2025.
On the financial front, the Royal Arc Electrodes IPO reported revenue of ₹46 crore for 30 Sep 2024, compared with ₹101 crore for 31 Mar 2024. The Royal Arc Electrodes IPO PAT was ₹3 crore against ₹12 crore. The Royal Arc Electrodes IPO net worth as of 30 Sep 2024 was ₹45 crore.
Always verify The Royal Arc Electrodes IPO details and GMP data with the official offer document before investing in the Royal Arc Electrodes IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Sep 2024
31 Mar 2024
31 Mar 2023
Total Assets
56
52
44
Revenue
46
101
98
PAT
3
12
10
Net Worth
45
42
30
Reserves
36
33
29
Total Borrowing
2
0
1
Royal Arc Electrodes IPO Financials FAQs
Revenue of Royal Arc Electrodes (Amount in ₹ Crore) — 30 Sep 2024: 46; 31 Mar 2024: 101; 31 Mar 2023: 98. Profit after tax (PAT) — 30 Sep 2024: 3; 31 Mar 2024: 12; 31 Mar 2023: 10.
Total assets — 30 Sep 2024: 56; 31 Mar 2024: 52; 31 Mar 2023: 44. Net worth — 30 Sep 2024: 45; 31 Mar 2024: 42; 31 Mar 2023: 30. Reserves & surplus — 30 Sep 2024: 36; 31 Mar 2024: 33; 31 Mar 2023: 29. (Amount in ₹ Crore)
Total borrowing of Royal Arc Electrodes (Amount in ₹ Crore) — 30 Sep 2024: 2; 31 Mar 2024: 0; 31 Mar 2023: 1.
The financials shown for Royal Arc Electrodes IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
